Document is current
Any future updates will be listed below
-
Authors
Yonesaka, Kimio https://orcid.org/0000-0002-0816-5315
Tanaka, Kaoru
Kitano, Mutsukazu
Kawakami, Hisato https://orcid.org/0000-0002-3280-4850
Hayashi, Hidetoshi
Takeda, Masayuki
Sakai, Kazuko
Nishio, Kazuto
Doi, Katsumi
Nakagawa, Kazuhiko https://orcid.org/0000-0003-1284-9776
- License Information
-
More Information
Article History
Received: 14 May 2019
Revised: 10 September 2019
Accepted: 12 September 2019
First Online: 30 September 2019
Conflict of interest
: Yonesaka reports grants and personal fees from Boehringer Ingelheim. Hayashi reports grants and personal fees from Boehringer Ingelheim and AstraZeneca. Takeda reports personal fees from Boehringer Ingelheim. Tanaka reports personal fees from Boehringer Ingelheim, AstraZeneca, and Bristol-Myers Squibb. Nishio reports grants from Boehringer Ingelheim. Nakagawa reports grants and personal fees from AstraZeneca, Boehringer Ingelheim, Astellas Pharma, Bristol-Myers Squibb, and Daiichi-sankyo, and personal fees from Pfizer. The remaining authors declare that they have no conflict of interest.
